C
Celldex Therapeutics, Inc. (CLDX)
NCM – Real vaqt narxi. Valyuta: USD
32.00
-0.28 (-0.87%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
32.00
-0.28 (-0.87%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Celldex Therapeutics, Inc., biopharmaceutical kompaniyasi, og'ir yallig'lanish, allergik, otoimmün va boshqa kasalliklarga chalingan bemorlar uchun terapevtik antitelalarni ishlab chiqish bilan shug'ullanadi. Kompaniyaning dori nomzodlari orasida mavjud davolash usullari etarli bo'lmagan mast hujayralari vositachiligidagi kasalliklarni davolash uchun ishlab chiqilgan monoklonal va bispesifik antitelalar mavjud. Kompaniya surunkali ürtiker, prurigo nodülarisi, eozinofilik ezofagit va atopik dermatitni davolash uchun KIT retseptoriga xos bo'lgan va uning faoliyatini kuchli inhibe qiluvchi monoklonal antitelasi bo'lgan Barzolvolimab (CDX-0159) va yallig'lanish kasalliklari uchun bispesifik nomzod bo'lgan CDX-622 kabi klinik dasturlarni ishlab chiqadi. surunkali yallig'lanishni keltirib chiqaradigan ikkita komplementar yo'nalishni maqsad qiladi, alarmin timik stromal limfopoietinni kuchli zararsizlantiradi va ildiz hujayrasi omilining ochligi orqali mast hujayralarini yo'q qiladi. Celldex Therapeutics, Inc. Nyu-Jersi shtatining Hampton shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Diane C. Young M.D. | Senior VP & Chief Medical Officer |
| Dr. Margo Heath-Chiozzi M.D. | Senior Vice President of Regulatory Affairs |
| Dr. Ronald A. Pepin Ph.D. | Chief Business Officer & Senior VP |
| Dr. Tibor Keler Ph.D. | Founder, Chief Scientific Officer & Executive VP |
| Mr. Anthony S. Marucci M.B.A. | Founder, President, CEO & Director |
| Mr. Freddy A. Jimenez Esq. | Senior VP & General Counsel |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-05-07 | 10-Q | cldx-20260331x10q.htm |
| 2026-04-29 | DEF 14A | tm261321-3_def14a.htm |
| 2026-04-29 | ARS | tm261066d3_ars.pdf |
| 2026-04-02 | 8-K | tm267111d2_8k.htm |
| 2026-02-25 | 8-K | f8k_022526.htm |
| 2026-02-25 | 10-K | cldx-20251231x10k.htm |
| 2025-11-10 | 8-K | f8k_111025.htm |
| 2025-08-19 | 8-K | tm2523903d1_8k.htm |
| 2025-08-07 | 8-K | f8k_080625.htm |
| 2025-06-06 | 8-K | tm2517205d1_8k.htm |
| Ms. Elizabeth Crowley | Chief Product Development Officer & Senior VP |
| Ms. Sarah Cavanaugh | Senior Vice President of Corporate Affairs & Administration |
| Ms. Teri L. Lawver | SVP & Chief Commercial Officer |
| Prof. Joseph P. Schlessinger Ph.D. | Co-Founder & Member of Scientific Advisory Board |